Andere Sprachen Filament Health Corp.

Aktien

A3CY3J

CA31685W1068

FLHLF

Markt geschlossen - OTC Markets Andere Börsenplätze 21:59:31 06.05.2024			% 5 Tage	% 1. Jan.
0.0365 ^USD	-1.08%		+6.10%	-32.53%

04.05.	Filament Health Corp. kündigt Wechsel im Vorstand an	CI
03.04.	Filament Health Corp. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS	04.05.
Filament Health Corp. Announces Change to Board of Directors	04.05.
FILAMENT HEALTH TO DISCUSS ITS DRUG DEVELOPMENT PLATFORM IN FIRESIDE CHAT WITH WATER TOWER RESEARCH ON APRIL 4, 2024 AT 12PM ET	03.04.
FILAMENT HEALTH REPORTS Q4 AND YEAR END 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS	03.04.
Filament Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	03.04.
FILAMENT HEALTH ANNOUNCES APPOINTMENT OF MICHAEL MESSINGER TO ITS BOARD OF DIRECTORS	28.03.
Filament Health Corp. Announces Appointment of Michael Messinger to Its Board of Directors and Chair of the Audit Committee	28.03.
Filament Health Corp. Announces Chief Financial Officer Changes	28.03.
FILAMENT HEALTH ANNOUNCES SHIPMENTS OF BOTANICAL PSILOCYBIN TO FOUR COUNTRIES FOR CLINICAL INVESTIGATION	19.03.
Filament Health Corp. Announces Shipments of Botanical Psilocybin to Four Countries for Clinical Investigation	19.03.
FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO ISRAEL	15.02.
Filament Health Corp. Completes the First Export of Botanical Psilocybin to Israel	15.02.
FILAMENT HEALTH ANNOUNCES FDA OPENING OF INVESTIGATIONAL NEW DRUG APPLICATION FOR SUBSTANCE USE DISORDERS	31.01.
Filament Health Announces FDA Opening of Investigational New Drug Application for Substance Use Disorders	31.01.
Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regions	31.01.
FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO AUSTRALIA	17.01.
Filament Health Completes the First Export of Biological Psilocybin to Australia	17.01.
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS	03.01.
Filament Health Announces Change to Board of Directors	03.01.
FILAMENT HEALTH ANNOUNCES TERMINATION OF PROPOSED BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION	20.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Filament Health Corp.

Aktien

A3CY3J

CA31685W1068

FLHLF

Andere Sprachen

Filter